Common Hyperpigmentation Disorders in Adults: Part II. Melanoma, Seborrheic Keratoses, Acanthosis Nigricans, Melasma, Diabetic Dermopathy, Tinea Versicolor, and Postinflammatory Hyperpigmentation

American Family Physician

Volumn 68, Issue 10, 2003, Pages 1963-1968

  Stulberg, Daniel L ^a   Clark, Nicole ^a   Tovey, Daniel ^b  

^a Utah Valley Fam Pract Resid Prog   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BLEACHING AGENT; CONTRACEPTIVE AGENT; ESTROGEN; FLUOCINOLONE ACETONIDE; HYDROQUINONE; RETINOIC ACID; SELENIUM SULFIDE;

ACANTHOSIS NIGRICANS; BENIGN TUMOR; CANCER CLASSIFICATION; CELL STIMULATION; CHLOASMA; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; HYPERPIGMENTATION; INSULIN RESISTANCE; LOW LEVEL LASER THERAPY; MELANOCYTE; MELANOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; REVIEW; SEBORRHEIC KERATOSIS; SKIN CANCER; SKIN DISEASE; SYMPTOM; TINEA VERSICOLOR; TREATMENT INDICATION;

ACANTHOSIS NIGRICANS; ADULT; CHILD; DIABETES COMPLICATIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERPIGMENTATION; INFLAMMATION; MALE; MELANOMA; NEVUS; PREGNANCY; TINEA VERSICOLOR;

EID: 0345303670     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. What you should know about melanoma. Atlanta: American Cancer Society, 1999.
2. Goldstein BG, Goldstein AO. Diagnosis and management of malignant melanoma. Am Fam Physician 2001;63:1359-68,1374.
3. Jimbow K, Quevedo WC Jr, Fitzpatrick TB, Szabó G. Biology of melanocytes. In: Freedberg IM, Fitzpatrick TB, eds. Fitzpatrick's Dermatology in general medicine. 4th ed. New York: McGraw-Hill, 1993:261-89.
4. Benign skin tumors. In: Habif TP. Clinical dermatology: a color guide to diagnosis and therapy. 3d ed. St. Louis: Mosby, 1996:627-48.
5. Paron NG, Lambert PW. Cutaneous manifestations of diabetes mellitus. Prim Care 2000;27:371-83.
6. Dabelea D, Pettitt DJ, Jones KL, Arslanian SA. Type 2 diabetes mellitus in minority children and adolescents. An emerging problem. Endocrinol Metab Clin North Am 1999;28:709-29,viii.
7. Scott CR, Smith JM, Cradock MM, Pihoker C. Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics 1997;100: 84-91.
8. Kim NY, Pandya AG. Pigmentary diseases. Med Clin North Am 1998;82:1185-207.
9. Rendon MI, Cruz PD Jr, Sontheimer RD, Bergstresser PR. Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin. J Am Acad Dermatol 1989;21(3 pt 1):461-9.
10. Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 2002;146:228-37.
11. Kroumpouzos G, Cohen LM. Dermatoses of pregnancy. J Am Acad Dermatol 2001;45:1-19.
12. Taylor SC, Torok H, Jones T, Lowe N, Rich P, Tschen E, et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis 2003;72:67-72.
13. Grimes PE. Skin and hair cosmetic issues in women of color. Dermatol Clin 2000;18:659-65.
14. Dover JS, Arndt KA, Dinehart SM, Fitzpatrick RE, Gonzalez E. Guidelines of care for laser surgery. American Academy of Dermatology Guidelines/ Outcomes Committee. J Am Acad Dermatol 1999; 41(3 pt 1):484-95.
15. Sibbald RG, Landolt SJ, Toth D. Skin and diabetes. Endocrinol Metab Clin North Am 1996;25:463-72.
16. Ferringer T, Miller F 3d. Cutaneous manifestations of diabetes mellitus. Dermatol Clin 2002;20:483-92.
17. Faergemann J. Pityrosporum infections. J Am Acad Dermatol 1994;31(3 pt 2):S18-20.
18. Nazzaro-Porro M, Passi S. Identification of tyrosinase inhibitors in cultures of Pityrosporum. J Invest Dermatol 1978;71:205-8.
19. Crawford F, Hart R, Bell-Syer S, Torgerson D, Young P, Russell I. Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev 2003;(2):CD001434.
20. Bell-Syer SE, Hart R, Crawford F, Torgerson DJ, Tyrrell W, Russell I. Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst Rev 2003;(2):CD003584.
21. Lange DS, Richards HM, Guarnieri J, Humeniuk JM, Savin RC, Reyes BA, et al. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 1998;39:944-50.
22. Ruiz-Maldonado R, Orozco-Covarrubias ML. Post-inflammatory hypopigmentation and hyperpigmentation. Semin Cutan Med Surg 1997;16:36-43.